Description
The New York State Department of Health intends to contract with Revvity Health Sciences, Inc. for the purchase of two genetic screening processors for the Newborn Screening Program. The term is 11/10/2025-3/31/2027. A competitive procurement was not feasible because Revvity Health Sciences, Inc. is the sole manufacturer and service provider of the genetic screening processors.
Attached files
The solicitation documents live at the source — open the bid source above to download them.